PATHOLOGICAL COMPLETE RESPONSE AFTER PLATINUM-BASED CHEMOTHERAPY IN MALIGNANT PLEURAL MESOTHELIOMA

被引：0
|
作者：
Kumar, Sanjeev S. [1 ]
Boyer, Michael [1 ]
Kenney, Cathy [2 ]
Mccaughan, Brian [3 ]
Kao, Steven [1 ]
机构：
[1] Royal Prince Alfred Hosp, Dept Med Oncol, Camperdown, NSW, Australia
[2] Univ Sydney, Sydney, NSW 2006, Australia
[3] Royal Prince Alfred Hosp, Dept Cardiothorac Surg, Camperdown, NSW, Australia
来源：
JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷
关键词：
mesothelioma; chemotherapy; response;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.14-012
引用
收藏
页码：S1239 / S1239
页数：1
相关论文
共 50 条
  • [41] CHEMOTHERAPY FOR MALIGNANT PLEURAL MESOTHELIOMA - CAMEO
    JETT, JR
    EAGAN, RT
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1982, 125 (04): : 82 - 82
  • [42] Budget impact analysis of ttfields plus platinum-based therapy for first-line malignant pleural mesothelioma
    Wang, Bruce C.
    Furnback, Wesley
    Proescholdt, Christina
    Chavez, Gordon
    CANCER RESEARCH, 2020, 80 (16)
  • [43] Chemotherapy in malignant pleural mesothelioma: A review
    Ong, ST
    Vogelzang, NJ
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (03) : 1007 - 1017
  • [44] Predicting Response and Outcome After Platin-Based Chemotherapy and New, Targeted Approaches in Malignant Pleural Mesothelioma
    Mairinger, Fabian Dominik
    Borchert, Sabrina
    Wessolly, Michael
    Mairinger, Elena
    Kollmeier, Jens
    Christoph, Daniel
    Eberhardt, Wilfried
    Hegedus, Balazs
    Suckrau, Pia Maria
    Hager, Thomas
    Sydow, Saskia Roxanne
    Ohlig, Henning
    Wyrich, Martine
    Radke, Julia
    Herold, Thomas
    Mairinger, Thomas
    Aigner, Clemens
    Schmid, Kurt Werner
    Bankfalvi, Agnes
    Wohlschlaeger, Jeremias
    Walter, Robert
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 123 - 123
  • [45] Pemetrexed Combined with Platinum-based Chemotherapy for Advanced Malignant Peritoneal Mesothelioma: Retrospective Analysis of Six Cases
    Nakano, Michitaka
    Kusaba, Hitoshi
    Makiyama, Akitaka
    Ariyama, Hiroshi
    Arita, Shuji
    Oda, Hisanobu
    Esaki, Taito
    Takayoshi, Kotoe
    Uchino, Keita
    Tamura, Shingo
    Kumagai, Hozumi
    Iwama, Eiji
    Shirakawa, Tsuyoshi
    Mitsugi, Kenji
    Takaishi, Shigeo
    Akashi, Koichi
    Baba, Eishi
    ANTICANCER RESEARCH, 2014, 34 (1A) : 215 - 220
  • [46] HIGH RESPONSE OF SECOND-LINE CHEMOTHERAPY WITH PEMETREXED COMBINED WITH CARBOPLATIN IN PATIENTS WITH UNRESECTABLE MALIGNANT MESOTHELIOMA EXPERIENCING PROGRESSION AFTER THREE MONTHS OF CONCLUDING PLATINUM-BASED CHEMOTHERAPY
    Morales-Espinosa, Daniela
    Arrieta, Oscar
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1366 - S1367
  • [47] Feasibility of Tumor Treating Fields with Pemetrexed and Platinum-Based Chemotherapy for Unresectable Malignant Pleural Mesothelioma: Single-Center, Real-World Data
    Kutuk, Tugce
    Appel, Haley
    Avendano, Maria Carolina
    Albrecht, Federico
    Kaywin, Paul
    Ramos, Suyen
    Suarez-Murias, Melanie E.
    Mehta, Minesh P.
    Kotecha, Rupesh
    CANCERS, 2022, 14 (08)
  • [48] Second-line treatment with pemetrexed following platinum based doublet chemotherapy in Malignant Pleural Mesothelioma
    Sorensen, J. B.
    Perell, K.
    Thielsen, A. K.
    EJC SUPPLEMENTS, 2005, 3 (02): : 337 - 337
  • [49] Effective Chemotherapy Based on a Chemosensitivity Test for Malignant Pleural Mesothelioma
    Maniwa, Yoshimasa
    Yoshimura, Masahiro
    Takata, Masahiko
    Nishimura, Yoshihiro
    Ohno, Yoshiharu
    ANNALS OF THORACIC AND CARDIOVASCULAR SURGERY, 2008, 14 (05) : 319 - 321
  • [50] Response of malignant pleural mesothelioma to chemotherapy does not confer a survival advantage
    Fennell, D
    Steele, J
    Sheaff, M
    Evans, M
    Shamash, J
    Wells, P
    Rudd, R
    LUNG CANCER, 2005, 49 : S220 - S220
12345